Carprofen Market

Carprofen is a nonsteroidal anti-inflammatory drug (NSAID) that veterinarians prescribe as a supportive treatment for various conditions in animals. It provides day-to-day treatment for pain and inflammation from various kinds of joint pain as well as post-operative pain.
Carprofen Market aims to provide a comprehensive presentation of the global market for Carprofen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carprofen. Carprofen Market contains market size and forecasts of Carprofen in global, including the following market information:
Global Carprofen Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Carprofen Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Carprofen companies in 2022 (%)
The global Carprofen market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Ibuprofen Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Carprofen include Zoetis, Chanelle Pharma, AVENTIX, KRKA UK Ltd, Dechra, Parnell, VetUK, Norbrook and Alivira Animal Health, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Wesurveyed the Carprofen manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Carprofen Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Carprofen Market Segment Percentages, by Type, 2022 (%)
Ibuprofen
Naproxen
Ketoprofen
Global Carprofen Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Carprofen Market Segment Percentages, by Application, 2022 (%)
Dog
Cat
Horse
Others
Global Carprofen Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Carprofen Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Carprofen revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Carprofen revenues share in global market, 2022 (%)
Key companies Carprofen sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Carprofen sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Zoetis
Chanelle Pharma
AVENTIX
KRKA UK Ltd
Dechra
Parnell
VetUK
Norbrook
Alivira Animal Health
Vedco Inc
ElancoDVM
Vethical
Vetoquinol
Pivetal
Outline of Major Chapters:
Chapter 1: Introduces the definition of Carprofen, market overview.
Chapter 2: Global Carprofen market size in revenue and volume.
Chapter 3: Detailed analysis of Carprofen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Carprofen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Carprofen capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.